目的 探析阿立哌唑口腔崩解片对女性精神分裂症患者的治疗效果。方法 随机抽取2015年2月-2016年7月来我院接 受治疗的76例女性精神分裂症患者的临床诊疗资料，并依据药物治疗差异分为实验组(38例)和对照组(38例)。实验 组和对照组患者分别接受阿立哌唑口腔崩解片和利培酮片治疗，比较两组患者的PANSS评分及不良反应发生状况。 结果 实验组患者治疗后的阴性症状、阳性症状、精神病理得分及PANSS总分均低于治疗前(P＜0.05)；实验组治疗 有效率为89.47%显著高于对照组治疗有效率(86.84%)(P＜0.05)；同时实验组患者的不良反应发生率(7.89%)显著低 于对照组(21.05%)(P＜0.05)。结论 阿立哌唑口腔崩解片对女性精神分裂症患者的治疗效果较好，且其安全性高、 不良反应发生率低，值得继续应用于临床治疗中。

Objective To investigate into the therapeutic effects of Aripiprazole on the female schizophrenics. Methods We have sampled at random 76 cases of female schizophrenics treated in our hospital between February of 2015 and July of 2016, by analyzing their clinical diagnosis, we divided them into experimental group (38 samples) and control group (38 samples). The former group received the treatment of Aripiprazole, while the latter, of Risperidone Tablets. We compared the results of their PANSS and any adverse reactions during the experiment. Results After the treatment, patients from the experimental group showed a lower level in negative symptom, positive symptom, general psychopathology symptom and PANSS when compared with before. (P<0.05). The effective rate of treatment in experimental group was 89.47%, which was notably higher than control group ( 86.84%) (P<0.05). At the same time, the adverse reaction rate of experimental group (7.89%) was notably lower than the control group (21.05%)(P<0.05). Conclusion Aripiprazole showed great curative effects on the treatment of female schizophrenics, with better security and lower negative reaction rate. So it’s worthy to be applied in the clinical use.